Moberg Pharma Q1: A strong start ahead of the high season - Redeye

Q1 confirms that Moberg’s Terclara is the market leader in Sweden and that Terclara is on track for a Norwegian launch into the current high season for 2025. In the current Q2 period, sales and the OPEX base will reflect the current launch and market activities in Sweden and Norway.

Länk till analysen i sin helhet: https://www.redeye.se/research/1107846/moberg-pharma-q1-a-strong-start-ahead-of-the-high-season?utm_source=finwire&utm_medium=RSS